Brain Scientific (OTCQB: BRSF), a Florida-based applied science technology company, announced that its NeuroCap(TM) has been fully tested by Brainbox, a leading CRO with decades of expertise; as a result of the positive test outcomes, Brainbox will be integrating NeuroCap into its client solutions and applications. BrainBox officials noted that the NeuroCap devices performed “extremely well” and that the company plans to use the devices in its sports medicine and pharmaceutical CRO spaces. Brainbox provides a wide range of customizable solutions that combine decades of technical and academic expertise with expert hands-on training to meet the demands of all types and kinds of noninvasive brain stimulation research studies. “We’re excited to see the results of Brainbox’s testing of our game-changing NeuroCap,” said Brain Scientific CEO Hassan Kotob in the press release. “Their deep technical and academic expertise is highly respected and well-known and validates that the NeuroCap is a modern and innovative solution to further important research in sports medicine and pharmaceuticals.”
To view the full press release, visit https://ibn.fm/xsQ3O
About Brain Scientific Inc.
Brain Scientific is an applied sciences technology company with multiple patents and FDA-cleared products. Brain Scientific is committed to developing next-gen solutions that advance the future of medical and OEM devices. Brain Scientific has two product lines covering neurology and precision motion. The NeuroCap(TM) and NeuroEEG(TM) are smart neurological diagnostic devices that simplify administration, shorten scan time and cut costs. The Piezo Motion product line consists of ultraefficient compact precision motors that will drive the next generation of OEM devices. To learn more about the company, visit www.BrainScientific.com.
NOTE TO INVESTORS: The latest news and updates relating to BRSF are available in the company’s newsroom at https://ibn.fm/BRSF
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.
As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.
For more information, please visit https://www.investorwire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]
InvestorWire is part of the InvestorBrandNetwork.